Cargando…
Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030380/ https://www.ncbi.nlm.nih.gov/pubmed/27471864 http://dx.doi.org/10.1038/bcj.2016.55 |
| _version_ | 1782454668493848576 |
|---|---|
| author | Jacobus, S J Rajkumar, S V Weiss, M Stewart, A K Stadtmauer, E A Callander, N S Dreosti, L M Lacy, M Q Fonseca, R |
| author_facet | Jacobus, S J Rajkumar, S V Weiss, M Stewart, A K Stadtmauer, E A Callander, N S Dreosti, L M Lacy, M Q Fonseca, R |
| author_sort | Jacobus, S J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5030380 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50303802016-09-26 Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen Jacobus, S J Rajkumar, S V Weiss, M Stewart, A K Stadtmauer, E A Callander, N S Dreosti, L M Lacy, M Q Fonseca, R Blood Cancer J Letter to the Editor Nature Publishing Group 2016-07 2016-07-29 /pmc/articles/PMC5030380/ /pubmed/27471864 http://dx.doi.org/10.1038/bcj.2016.55 Text en Copyright © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Jacobus, S J Rajkumar, S V Weiss, M Stewart, A K Stadtmauer, E A Callander, N S Dreosti, L M Lacy, M Q Fonseca, R Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen |
| title | Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen |
| title_full | Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen |
| title_fullStr | Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen |
| title_full_unstemmed | Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen |
| title_short | Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen |
| title_sort | randomized phase iii trial of consolidation therapy with bortezomib–lenalidomide–dexamethasone (vrd) vs bortezomib–dexamethasone (vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030380/ https://www.ncbi.nlm.nih.gov/pubmed/27471864 http://dx.doi.org/10.1038/bcj.2016.55 |
| work_keys_str_mv | AT jacobussj randomizedphaseiiitrialofconsolidationtherapywithbortezomiblenalidomidedexamethasonevrdvsbortezomibdexamethasonevdforpatientswithmultiplemyelomawhohavecompletedadexamethasonebasedinductionregimen AT rajkumarsv randomizedphaseiiitrialofconsolidationtherapywithbortezomiblenalidomidedexamethasonevrdvsbortezomibdexamethasonevdforpatientswithmultiplemyelomawhohavecompletedadexamethasonebasedinductionregimen AT weissm randomizedphaseiiitrialofconsolidationtherapywithbortezomiblenalidomidedexamethasonevrdvsbortezomibdexamethasonevdforpatientswithmultiplemyelomawhohavecompletedadexamethasonebasedinductionregimen AT stewartak randomizedphaseiiitrialofconsolidationtherapywithbortezomiblenalidomidedexamethasonevrdvsbortezomibdexamethasonevdforpatientswithmultiplemyelomawhohavecompletedadexamethasonebasedinductionregimen AT stadtmauerea randomizedphaseiiitrialofconsolidationtherapywithbortezomiblenalidomidedexamethasonevrdvsbortezomibdexamethasonevdforpatientswithmultiplemyelomawhohavecompletedadexamethasonebasedinductionregimen AT callanderns randomizedphaseiiitrialofconsolidationtherapywithbortezomiblenalidomidedexamethasonevrdvsbortezomibdexamethasonevdforpatientswithmultiplemyelomawhohavecompletedadexamethasonebasedinductionregimen AT dreostilm randomizedphaseiiitrialofconsolidationtherapywithbortezomiblenalidomidedexamethasonevrdvsbortezomibdexamethasonevdforpatientswithmultiplemyelomawhohavecompletedadexamethasonebasedinductionregimen AT lacymq randomizedphaseiiitrialofconsolidationtherapywithbortezomiblenalidomidedexamethasonevrdvsbortezomibdexamethasonevdforpatientswithmultiplemyelomawhohavecompletedadexamethasonebasedinductionregimen AT fonsecar randomizedphaseiiitrialofconsolidationtherapywithbortezomiblenalidomidedexamethasonevrdvsbortezomibdexamethasonevdforpatientswithmultiplemyelomawhohavecompletedadexamethasonebasedinductionregimen |